Publication | Closed Access

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

ObesityMetabolic SyndromeSmall Dense LdlLipoprotein-associated Phospholipase A2BiochemistryMedicineMetabolic DiseasePhysiologyDiabetesHyperlipidemiaLipoprotein MetabolismMetabolismPharmacologyAtherosclerosisDyslipidemiaHealth Sciences